Back
Universal Insurance Holdings 10K Form
Sell
44
UVE
Universal Insurance Holdings
Last Price:
19.51
Seasonality Move:
61.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-30 | 10Q | UVE/Universal Insurance Holdings Quarterly |
| 2023-10-30 | 10Q | UVE/Universal Insurance Holdings Quarterly |
| 2023-07-31 | 10Q | UVE/Universal Insurance Holdings Quarterly |
| 2023-05-02 | 10Q | UVE/Universal Insurance Holdings Quarterly |
| 2023-02-17 | 10Q | UVE/Universal Insurance Holdings Quarterly |
| 2022-11-02 | 10Q | UVE/Universal Insurance Holdings Quarterly |
Receive UVE News And Ratings
See the #1 stock for the next 7 days that we like better than UVE
UVE Financial Statistics
Sales & Book Value
| Annual Sales: | $1.39B |
|---|---|
| Cash Flow: | $80.96M |
| Price / Cash Flow: | 2.45 |
| Annual Sales: | $14.15 |
| Price / Book: | 1.38 |
Profitability
| EPS (TTM): | 2.46000 |
|---|---|
| Net Income (TTM): | $72.91M |
| Gross Margin: | -- |
| Return on Equity: | 20.24% |
| Return on Assets: | 2.96% |
Universal Insurance Holdings Earnings Forecast
Key Universal Insurance Holdings Financial Ratios
- The Interest Expense is 8.71% of Operating Income.
- The Net Earning history of UVE is 4.80% of Total Revenues.
- Per Share Earnings over the last 30 years have been positive in 15 years.
Universal Insurance Holdings Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Insurance |
| Sector: | Financials |
| Current Symbol: | UVE |
| CUSIP: | 91359V |
| Website: | universalinsuranceholdings.com |
Debt
| Debt-to-Equity Ratio: | 0.25 |
|---|---|
| Current Ratio: | 2.5 |
| Quick Ratio: | 1.56 |
Price-to-Earnings
| Trailing P/E Ratio: | 8.78 |
|---|---|
| Forward P/E Ratio: | 7.36 |
UVE Technical Analysis vs Fundamental Analysis
Sell
44
Universal Insurance Holdings (UVE)
is a Sell
Is Universal Insurance Holdings a Buy or a Sell?
-
Universal Insurance Holdings stock is rated a Sell
The current Universal Insurance Holdings [UVE] share price is $19.50. The Score for UVE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.